Dyspepsia Terminated Phase 2 Trials for Recanaclotide (DB15417)

Also known as: Indigestion

IndicationStatusPhase
DBCOND0004526 (Dyspepsia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01712412Phase 2a Study of IW-9179 to Treat Functional DyspepsiaTreatment